Diabetes-Related Discrimination at Workplace and by Insurances

This study has been completed.
Sponsor:
Collaborator:
Diabetes Foundation Basel
Information provided by:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT00661908
First received: April 16, 2008
Last updated: NA
Last verified: April 2008
History: No changes posted
  Purpose

Diabetic subjects often report of problems at the workplace or when contracting insurances because of their diabetes.

By distributing a self-report questionnaire to insulin-treated Type 1 and Type 2 diabetic subjects we wanted to analyse the frequency of work- and insurance-related discrimination. Furthermore we wanted to detect socio-demographic and diabetes-related factors which are associated with increased discrimination at workplace and by insurances. We hypothesized that diabetes-related discrimination at workplace and by insurances exists and that certain factors like having severe hypoglycaemic events, being type 1 diabetic or being overweight would be associated with more problems at work or with insurances.


Condition
Insulin-Treated Diabetes Mellitus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Discrimination of Insulin-Treated Diabetic Subjects at the Workplace and by Insurances

Resource links provided by NLM:


Further study details as provided by University Hospital, Basel, Switzerland:

Enrollment: 509
Study Start Date: March 2004
Study Completion Date: January 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
insulin-treated diabetic subjects of North-western part of Switzerland

Detailed Description:

Our self report questionnaire included 83 items to assess treatment goals, quality of life and discrimination at workplace or by insurances. 636 questionnaires were distributed and were answered and returned. Anonymity was ensured. Patients were recruited from the diabetes outpatient clinic of the University of Basel Hospital, 5 regional hospitals, specialist practices and general practitioner practices.

The aims of this study are to investigate the prevalence of discrimination at workplace and by insurances due to diabetes mellitus. Furthermore we want analyse if socio-demographic factors (age,gender,origin) show an impact on diabetes-related discrimination at workplace and by insurances. We hypothesize furthermore that certain diabetes-related factors like having severe hypoglycemias, being type 1 diabetic, having diabetic complications or being overweight/obese is associated with more problems at work and with insurances.

Data will be analysed by a multiple ordinal regression analysis. We will correct data for age, gender, employment status and diabetes type.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Within a time period of two month we recruited all insulin-treated diabetic patients from the outpatient clinic of the University Hospital of Basel (n=203), from 5 regional hospitals (n=135) in the North-western part of Switzerland and from 13 specialist practices (n=107) as well as from 15 randomly selected general practioner practices (n=64)in the mentioned area.

Criteria

Inclusion Criteria:

  • german-speaking insulin-treated diabetic patients

Exclusion Criteria:

  • none
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00661908

Sponsors and Collaborators
University Hospital, Basel, Switzerland
Diabetes Foundation Basel
Investigators
Principal Investigator: Piera M Nebiker, MD University of Basel
  More Information

No publications provided

Responsible Party: Piera M Nebiker, MD, University Hospital of Basel, Switzerland
ClinicalTrials.gov Identifier: NCT00661908     History of Changes
Other Study ID Numbers: 274/03
Study First Received: April 16, 2008
Last Updated: April 16, 2008
Health Authority: Switzerland: Ethikkommission

Additional relevant MeSH terms:
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on October 23, 2014